Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society's ...
Jul 14, 2025
0
31
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine ...
Jul 14, 2025
0
14
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research raises important concerns about their use among adolescent boys and young men.
Jul 10, 2025
0
22
Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.
Jun 25, 2025
0
19
A new randomized clinical trial, led by a team of researchers from Wake Forest University School of Medicine and Wake Forest University, did not find evidence that wearing a weighted vest or engaging in resistance training ...
Jun 20, 2025
0
62
A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised weight-loss program, has found disparities among ethnic and sub-ethnic groups in how much weight they ...
May 14, 2025
0
12
The famed US diet company originally known as WeightWatchers said it has filed for bankruptcy but will continue operations while its $1.15-billion debt is restructured.
May 7, 2025
0
14
The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications.
Apr 7, 2025
0
12
Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently recommended six months—can more than double weight loss for patients who struggle initially with lifestyle ...
Mar 18, 2025
0
54
University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that tirzepatide and semaglutide provide ...
